These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

677 related items for PubMed ID: 14585410

  • 1. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE, Koneru B, Baramipour P, Fisher A, Barone A, Wilson D, Dela Torre A, Cho KC, Contractor D, Korogodsky M.
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T, Nagata K, Hasuike S, Onaga M, Motoda M, Moriuchi A, Iwakiri H, Uto H, Kato J, Ido A, Hayashi K, Tsubouchi H.
    J Gastroenterol; 2003 Nov; 38(10):977-81. PubMed ID: 14614605
    [Abstract] [Full Text] [Related]

  • 3. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, El-Malah A.
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [Abstract] [Full Text] [Related]

  • 4. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, Hasegawa S, Tsubouchi H, Kagoshima Liver Cancer Study Group.
    J Hepatobiliary Pancreat Surg; 2009 Sep; 16(3):359-66. PubMed ID: 19300896
    [Abstract] [Full Text] [Related]

  • 5. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO, Kim SK, Son BH, Yoo CH, Hong HP, Cho YK, Kim BI.
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
    [Abstract] [Full Text] [Related]

  • 6. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH, Tzeng CW, Smith JK, Eckhoff DE, Bynon JS, Wang T, Arnoletti JP, Heslin MJ.
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [Abstract] [Full Text] [Related]

  • 7. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
    Xia JL, Ye SL, Zou JH, Ren ZG, Gan YH, Wang YH, Chen Y, Ge NL, Tang ZY, Yang BH.
    Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186
    [Abstract] [Full Text] [Related]

  • 8. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.
    Lam VW, Ng KK, Chok KS, Cheung TT, Yuen J, Tung H, Tso WK, Fan ST, Poon RT.
    J Am Coll Surg; 2008 Jul; 207(1):20-9. PubMed ID: 18589357
    [Abstract] [Full Text] [Related]

  • 9. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
    Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Huo TI, Huang YH, Wu WC, Lin HC, Lee SD, Wu JC.
    J Clin Gastroenterol; 2012 Jan; 46(1):62-70. PubMed ID: 21934530
    [Abstract] [Full Text] [Related]

  • 10. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C, Corso R, Rampoldi A, Vinci M, Belli LS, Vangeli M, Solcia M, Castoldi C, Prisco C, Vanzulli A, Pinzello G.
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
    Fontana RJ, Hamidullah H, Nghiem H, Greenson JK, Hussain H, Marrero J, Rudich S, McClure LA, Arenas J.
    Liver Transpl; 2002 Dec; 8(12):1165-74. PubMed ID: 12474157
    [Abstract] [Full Text] [Related]

  • 13. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J, Chen MH, Yang W, Wu W, Yan K.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [Abstract] [Full Text] [Related]

  • 14. Radiofrequency ablation with hand-assisted laparoscopic surgery for the treatment of hepatocellular carcinoma in the caudate lobe.
    Ishiko T, Beppu T, Sugiyama S, Masuda T, Takahashi M, Komori H, Takamori H, Hirota M, Kanemitu K, Baba H.
    Surg Laparosc Endosc Percutan Tech; 2008 Jun; 18(3):272-6. PubMed ID: 18574414
    [Abstract] [Full Text] [Related]

  • 15. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
    Cha C, Fong Y, Jarnagin WR, Blumgart LH, DeMatteo RP.
    J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
    [Abstract] [Full Text] [Related]

  • 16. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
    Raut CP, Izzo F, Marra P, Ellis LM, Vauthey JN, Cremona F, Vallone P, Mastro A, Fornage BD, Curley SA.
    Ann Surg Oncol; 2005 Aug; 12(8):616-28. PubMed ID: 15965731
    [Abstract] [Full Text] [Related]

  • 17. [Radiofrequency ablation of malignant liver tumors: use of a volumetric necrosis-tumor ratio for local control].
    Kühl H, Stattaus J, Kühl B, Boes T, Antoch G, Frilling A, Forsting M.
    Rofo; 2006 Dec; 178(12):1243-9. PubMed ID: 17136648
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M, Yoshida H, Obi S, Sato S, Koike Y, Fujishima T, Tateishi R, Imamura M, Hamamura K, Teratani T, Shiina S, Ishikawa T, Omata M.
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [Abstract] [Full Text] [Related]

  • 19. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, Takahashi S, Toyota N, Ito K, Chayama K.
    J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
    [Abstract] [Full Text] [Related]

  • 20. Favorable alpha-fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation.
    Tsai MC, Wang JH, Hung CH, Kee KM, Yen YH, Lee CM, Hu TH, Chen CH, Lu SN.
    J Gastroenterol Hepatol; 2010 Mar; 25(3):605-12. PubMed ID: 20074164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.